The XPO1-ALK fusion is a rare alteration that was first described in the present report; additionally, this report describes the subsequent follow-up of a patient with NSCLC harboring the XPO1-ALK fusion. This evidence concerns the gene XPO1 and non-small cell lung carcinoma.